It is usual for a court to grant a final injunction after a finding of patent infringement. There has been some doubt about how this applied when the patents covered essential medical products. In Evalve v Edwards Lifescience [2010] EWHC 513 (Pat), the court explored the role of the public interest in withholding injunctions and awarding damages in lieu. It construed the public interest narrowly in part due to the existence of compulsory licences. This discussion explores the court’s reasoning and suggests that an even greater link with compulsory licences should be adopted.

中文翻译：

---

公益和专利禁令：Evalve诉Edwards Lifescience [2020] EWHC 513（Pat）

通常，法院会在发现专利侵权后授予最终禁令。对于当专利涵盖基本医疗产品时如何应用这种做法存在一些疑问。在Evalve诉Edwards Lifescience [2010] EWHC 513（Pat）一案中，法院探讨了公共利益在扣押禁令和代替损害赔偿中的作用。由于存在强制许可，它狭义地解释了公共利益。讨论探讨了法院的推理，并建议应与强制许可建立更大的联系。